Study for Novel Coronavirus Pneumonia (NCP)

Status Recruiting

Clinical Trial Summary

To develop practical and effective clinical diagnosis and treatment schemes for the control of novel coronavirus pneumonia.

Clinical Trial Description

By retrospectively analyzing the clinical epidemiological characteristics of the novel coronavirus pneumonia and the current diagnosis and treatment schemes, as well as in-depth analyzing the disease development process and outcome trends of NCP patients to develop practical and effective clinical diagnosis and treatment schemes and provide guarantee for the rapid control of the epidemic. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04283396
Study type	Observational
Source	Wuhan Union Hospital, China
Contact	Yang Jin
Phone	13554361146
Email	whunjy@126.com
Status	Recruiting
Phase
Start date	February 21, 2020
Completion date	July 30, 2020

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04798716` - The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19	Phase 1/Phase 2
Completed	`NCT05305456` - Clinical Trial Scheme of Tanreqing Capsules in the Treatment of COVID-19	Phase 3
Recruiting	`NCT04314271` - The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia
Recruiting	`NCT04282902` - A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection	Phase 3
Withdrawn	`NCT04285190` - The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19	N/A
Active, not recruiting	`NCT04273763` - Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)	N/A
Completed	`NCT04280224` - NK Cells Treatment for COVID-19	Phase 1
Completed	`NCT04273321` - Efficacy and Safety of Corticosteroids in COVID-19	N/A
Enrolling by invitation	`NCT04365309` - Protective Effect of Aspirin on COVID-19 Patients	Phase 2/Phase 3
Completed	`NCT04645407` - Effects of Fuzheng Huayu Tablets on COVID-19	Phase 4